D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
ITOS holding history
iTeos Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ITOS overviewAll 13F holders of ITOSFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 14
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −53,432−100.0% | Sold out | Holders |
| Q2 2025 | 53,432 | $532.7K | <0.1% | −50,693−48.7% | Reduced | Holders |
| Q1 2025 | 104,125 | $621.6K | <0.1% | +47,591+84.2% | Added | Holders |
| Q4 2024 | 56,534 | $434.2K | <0.1% | −69,227−55.0% | Reduced | Holders |
| Q3 2024 | 125,761 | $1.28M | <0.1% | −93,562−42.7% | Reduced | Holders |
| Q2 2024 | 219,323 | $3.25M | <0.1% | +82,603+60.4% | Added | Holders |
| Q1 2024 | 136,720 | $1.86M | <0.1% | −25,338−15.6% | Reduced | Holders |
| Q4 2023 | 162,058 | $1.77M | <0.1% | +47,600+41.6% | Added | Holders |
| Q3 2023 | 114,458 | $1.25M | <0.1% | +34,976+44.0% | Added | Holders |
| Q2 2023 | 79,482 | $1.05M | <0.1% | +6,816+9.4% | Added | Holders |
| Q1 2023 | 72,666 | $989.0K | <0.1% | +5,653+8.4% | Added | Holders |
| Q4 2022 | 67,013 | $1.31M | <0.1% | −18,732−21.8% | Reduced | Holders |
| Q3 2022 | 85,745 | $1.63M | <0.1% | +51,739+152.1% | Added | Holders |
| Q2 2022 | 34,006 | $701.0K | <0.1% | +34,006 | New | Holders |
| Q2 2021 | 0 | $0 | 0.0% | −7,742−100.0% | Sold out | Holders |
| Q1 2021 | 7,742 | $265.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.